Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
Abstract Introduction Anaplastic lymphoma kinase (ALK) gene rearrangements, have been identified in approximately 2-7% of patients with lung adenocarcinoma (LUAD). However, co-occurrence of double ALK fusions in one patient was rare. Herein, we reported two Chinese female LUAD patients with confirme...
Saved in:
Main Authors: | Hong Tao (Author), Zhe Liu (Author), Jing Mu (Author), Fei Gai (Author), Zhan Huang (Author), Liang Shi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALK positive histiocytosis in an adult female with an EML4-ALK RNA fusion
by: Jay Mehta, et al.
Published: (2020) -
Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer
by: Yongkuan Guo, et al.
Published: (2024) -
Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma
by: Pınar BULUTAY, et al.
Published: (2021) -
A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement
by: Yang Zheng, et al.
Published: (2024) -
Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
by: Chrisann Kyi, et al.
Published: (2021)